A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH. by Mohamed Osman, Anoop Mistry, Ada Keding, Rhian Gabe, Elizabeth Cook, Sarah Forrester, Rebecca Wiggins, Stefania Di Marco, Stefano Colloca, Loredana Siani, Riccardo Cortese, Deborah F Smith, Toni Aebischer, Paul M Kaye, Charles J Lacey

Connect to this object online.

Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised contro... by Kathy Baisley, MSc, Troy J Kemp, PhD, Aimée R Kreimer, PhD, Partha Basu, PhD, John Changalucha, MSc, Allan Hildesheim, PhD, Carolina Porras, MSc, Hilary Whitworth, PhD, Rolando Herrero, PhD, Charles J Lacey, MD, John T Schiller, PhD, Eric Lucas, MSc, Paul Mutani, MD, Joakim Dillner, PhD, Jackton Indangasi, MSc, Richard Muwonge, PhD, Richard J Hayes, DSc, Ligia A Pinto, PhD, Deborah Watson-Jones, PhD

Connect to this object online.

Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial by Deborah Watson-Jones, ProfPhD, John Changalucha, MSc, Hilary Whitworth, PhD, Ligia Pinto, PhD, Paul Mutani, MD, Jackton Indangasi, MSc, Troy Kemp, PhD, Ramadhan Hashim, BSc, Beatrice Kamala, Dip, Rebecca Wiggins, PhD, Twaib Songoro, BA, Nicholas Connor, MSc, Gladys Mbwanji, MSc, Miquel A Pavon, PhD, Brett Lowe, MSc, Devis Mmbando, BSc, Saidi Kapiga, ProfPhD, Philippe Mayaud, ProfMD, Silvia de SanJosé, MD, Joakim Dillner, ProfPhD, Richard J Hayes, ProfDSc, Charles J Lacey, ProfMD, Kathy Baisley, MSc

Connect to this object online.